S2Medical AB (S2M) — Cash Flow Reinvestment Rate
S2Medical AB (S2M) has a Cash Flow Reinvestment Rate of 2.99x as of December 2025, reinvesting Skr2.02 Million (capex Skr2.02 Million ) from operating cash flow of Skr676.00K. Check S2Medical AB (S2M) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
S2Medical AB Cash Flow Reinvestment Rate (2024–2025)
Historical reinvestment intensity for S2Medical AB across 2 annual periods. Explore how well can S2Medical AB service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for S2Medical AB (2024–2025)
Year-by-year capital reinvestment analysis for S2Medical AB. For live market cap and broader valuation context, see market value of S2Medical AB.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.00x | Skr675.00K | Skr675.00K | Skr675.00K | ▲ +296.8% |
| 2024 | 0.25x | Skr1.27 Million | Skr5.03 Million | Skr634.00K | — |